239
Participants
Start Date
November 9, 2017
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
OPC-64005
OPC-64005 film coated tablets
Atomoxetine
Atomoxetine gelatin capsules
Placebo
OPC-64005-matching placebo film coated tablets and atomoxetine-matching placebo gelatin capsules
Eastside Comprehensive Medical Center, LLC., New York
The Medical Research Network, LLC, New York
iResearch Atlanta, Decatur
Northwest Behavioral Research Center, Marietta
Clinical Neuroscience Solutions, Inc, Jacksonville
Clinical Neuroscience Solutions, Inc., Orlando
Clinical Neuroscience Solutions Inc., Orlando
Behavioral Clinical Research, Inc., North Miami
Innovative Clinical Research, Inc., Lauderhill
Meridien Research, Bradenton
Psychiatric Associates, Overland Park
Premier Psychiatric Research Institute, LLC, Lincoln
IPS Research Company, Oklahoma City
Paradigm Research Professionals, Oklahoma City
Clinical Trials of Texas, Inc., San Antonio
MCB Clinical Research Centers, LLC, Colorado Springs
Aspen Clinical Research, Orem
Center for Psychiatry and Behavioral Medicine Inc., Las Vegas
Southern California Research, LLC, Beverly Hills
Artemis Institute for Clinical Research, San Marcos
Artemis Institute for Clinical Research, San Diego
Collaborative Neuroscience Network, LLC, Garden Grove
Oregon Center for Clinical Investigators, Inc., Portland
Oregon Center for Clinical Investigators, Inc., Salem
BTC of Lincoln, Lincoln
Neuropsychiatric Associates, Woodstock
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY